ClinicalTrials.Veeva

Menu

Incidence of Cut-out Using Intramedullary Nails With Double Cephalic Screw vs. Unique in Pertrochanteric Fractures

M

Majadahonda Iron Gate University

Status

Not yet enrolling

Conditions

Proximal Femoral Fractures

Treatments

Device: Chimaera Nail (Orthofix)
Device: Gamma 3 Nail (Stryker)

Study type

Interventional

Funder types

Other

Identifiers

NCT06293495
CUT-OUT

Details and patient eligibility

About

The goal of this clinical trial is to compare outcomes in the treatment of proximal femur fractures. The main question it aims to answer is whether the use of a double cephalic screw prevents nail failure (cut-out).

Participants will be treated using open reduction and internal fixation with a proximal femoral nail. Researchers will compare intramedullary nailing with a single cephalic screw (Gamma nail) and with a double cephalic screw (Chimaera nail) to see the cut-out rate.

Full description

Randomized, open and prospective clinical trial.

Following the surgical indication for open reduction and internal fixation as treatment for proximal femoral fractures, patients will be randomly assigned (ratio 1:1) to one of the following treatments:

Control group: a Gamma 3 nail (single cephalic screw system) will be used for osteosynthesis of the fracture.

Experimental group: a Chimaera nail (system with double cephalic screw) will be used for osteosynthesis of the fracture.

Patient (or their legal guardian) must provide/sign the informed consent prior to inclusion in the study.

After the surgery, patients will be followed-up at 6 weeks, 3 and 6 months. At those times, data related to the radiological examination, the appearance of complications and the walking ability evaluation scale (FAC) will be collected.

Enrollment

200 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with proximal femur fracture (OTA/AO 31-A1, A2 and A3) requiring surgical treatment.
  • Signing of written informed consent according to current legislation before collecting any information, either by the patient or by the legal representative or by people linked by family ties.

Exclusion criteria

  • Presence of other fractures in the ipsilateral femur that condition the surgical treatment of the pertrochanteric femur fracture.
  • Subcapital fracture of the proximal femur.
  • Subtrochanteric fracture of the proximal femur.
  • Pathological fracture.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Single Cephalic Screw System
Active Comparator group
Description:
A Gamma 3 nail (single cephalic screw system) will be used for osteosynthesis of the fracture.
Treatment:
Device: Gamma 3 Nail (Stryker)
Double Cephalic Screw System
Experimental group
Description:
A Chimaera nail (system with double cephalic screw) will be used for osteosynthesis of the fracture.
Treatment:
Device: Chimaera Nail (Orthofix)

Trial contacts and locations

1

Loading...

Central trial contact

Pedro Jose Torrijos Garrido, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems